Testosterone Therapy Stroke — Increased Risk of Stroke
A stroke medical malpractice case identifies links between testosterone therapy and more strokes.
Testosterone Therapy Stroke – Facts of the Case
Gonzalo Mendez was 39 years old when he started using Depo-Testosterone. It was May 2011. In August 2011, Mendez was hospitalized and diagnosed with stroke. He had multiple acute infarctions. He was at an increased risk for further strokes. He had increased risk of death.
Testosterone Therapy and Increased Risk of Stroke
Mr. Mendez sued Pfizer. Pfizer is the manufacturer of Depo-Testosterone. His stroke lawyer is suing for damages caused by the stroke. The stroke lawyer claims that that the testosterone therapy manufacturer failed to warn about the link between testosterone therapy and increase risk of stroke.
Testosterone Therapy Stroke – FDA Warns of Link
The FDA approved testosterone products despite the increased risk of stroke.
Testosterone Therapy Stroke – VA Study Confirms Link
The VA confirms testosterone therapy stroke connection. The article is “Association of Testosterone Therapy With Mortality, Myocardial Infarction and Stroke in Men with Low Testosterone Levels.” The VA studied patients between 2005 and 2011. The study was published in the Journal of the American Medical Association (JAMA). It said that the “Use of testosterone therapy …. was associated with increased risk of death, MI or ischemic stroke.”
Testosterone Therapy Stroke – New England Journal of Medicing Confirms Link
In 2010, the New England Journal of Medicine published results of a similar study. That study confirmed testosterone therapy and increased risk of stroke. The researchers found that “testosterone gel was associated with an increased risk of lung adverse events.”
Testosterone Therapy Stroke – The Mendez Lawsuit
Medical malpractice lawyers claim that the drug company should have warned the public of the link between their medicine and stroke. They should have warned that testosterone therapy leads to more strokes.
There are legal claims for failure to warn, negligence, breach of warranties, fraud, negligent representation and violation of consumer protection laws.
Stroke lawyers claim that manufacturers focused ads only on the benefits of boosting one’s testosterone. That the drug company downplayed and failed to warn that their products lead to more strokes.
The information posted here on StrokeLaw.com is not to be interpreted as providing legal services or as proposing any form of legal advice. Nor should it be interpreted as offering any form of medical advice. All content is strictly intended for informational purposes only.